MaxCyte, Inc. (AIM: MXCT)
London
· Delayed Price · Currency is GBP · Price in GBX
280.00
-11.00 (-3.78%)
Oct 11, 2024, 2:59 PM GMT+1
MaxCyte Employees
MaxCyte had 143 employees as of December 31, 2023. The number of employees increased by 18 or 14.40% compared to the previous year.
Employees
143
Change (1Y)
18
Growth (1Y)
14.40%
Revenue / Employee
251.43K GBP
Profits / Employee
-196.05K GBP
Market Cap
300.24M
Employees Chart
MaxCyte News
- 2 days ago - MaxCyte to Report Third Quarter 2024 Financial Results on November 6, 2024 - GlobeNewsWire
- 3 days ago - MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer - GlobeNewsWire
- 9 days ago - Maxcyte: Reaching Financial Inflection With CASGEVY Ramp Up - Seeking Alpha
- 27 days ago - MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic Diseases - GlobeNewsWire
- 5 weeks ago - MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference - GlobeNewsWire
- 2 months ago - MaxCyte, Inc. (MXCT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - MaxCyte Reports Second Quarter and Half-Year 2024 Financial Results and Updates Full Year 2024 Guidance - GlobeNewsWire
- 3 months ago - MaxCyte to Report Second Quarter 2024 Financial Results on August 6, 2024 - GlobeNewsWire